Mantarray™ Mini Plates: Fewer Cells. More Data.

SEATTLE – Continuing our mission to enhance the accessibility and applicability of 3D tissue technology, Curi Bio is proud to announce the launch of the Mantarray Mini Plate, the latest advancement in our 3D Engineered Tissue Ecosystem. This new addition to our product lineup underscores our commitment to setting a new standard in the field, offering cost-effective and scalable solutions for researchers.

The Mantarray Mini Plate is designed to alleviate cell sourcing challenges while maintaining seamless compatibility with established assays and the reliable, high-quality results that researchers have come to expect from Curi Bio. By reducing the amount of biological material required for 3D Engineered Tissues, the Mantarray Mini Plate not only conserves valuable lab resources but also enables the performance of high-throughput studies with reduced financial impact. The new plates retain full compatibility with our flagship Mantarray Tissue Contractility platform and the Nautilai platform, ensuring that current users can adopt the new plates without any adjustments to their usual processes.

This development represents a significant step forward to meet the increasing demands of the scientific community for more efficient and economical research tools. 

Upcoming Webinar

Learn more about Mantarray Mini Plates at Curi Bio’s upcoming webinar on September 18, 2024 at 7am. The webinar is a perfect opportunity to gain more insight and ask any questions you might have during the live Q&A after the presentation.

More Info

For additional information about how the Mantarray Mini Plate can transform your research capabilities, or to inquire about our range of preclinical platform technologies, please reach out to us at contact@curibio.com.